Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial

Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., & Campieri, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.9370 · Cited by 1,485 · see citing works

A New Measure of Health Status for Clinical Trials in Inflammatory Bowel Disease

Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R. L., & Tompkins, C. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80080-0 · Cited by 1,289 · see citing works

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

Rembacken, B., Snelling, A. M., Hawkey, P. M., Chalmers, D. M., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,100 · see citing works

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

Madsen, K., Cornish, A. S., Soper, P., McKaigney, C. J., Jijon, H. B., Yachimec, C., Doyle, J. S. G., Jewell, L. D., & Simone, C. D. (2001) · Gastroenterology · doi:10.1053/gast.2001.27224 · Cited by 1,096 · see citing works

Pouchitis After Ileal Pouch-Anal Anastomosis: A Pouchitis Disease Activity Index

Sandborn, W. J., Tremaine, W. J., Batts, K. P., Pembérton, J. H., & Phillips, S. F. (1994) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61634-6 · Cited by 777 · see citing works

Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

Kruis, W., SCHÜTZ, E., Fric, P., Fixa, B., Judmaier, G., & Stolte, M. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00225.x · Cited by 774 · see citing works

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

Madsen, K. L., Doyle, J. S. G., Jewell, L. D., Tavernini, M. M., & Fedorak, R. N. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70013-2 · Cited by 761 · see citing works

J ileal pouch–anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients

Meagher, A. P., Farouk, R., Dozois, R. R., et al. (1998) · British journal of surgery · doi:10.1046/j.1365-2168.1998.00689.x · Cited by 616 · see citing works

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis

Venturi, Gionchetti, P., Rizzello, F., Johansson, Zucconi, Brigidi, P., Matteuzzi, & Campieri, M. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00560.x · Cited by 567 · see citing works

Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.

Penna, C., Dozois, R. R., Tremaine, W. J., Sandborn, W. J., LaRusso, N. A., Schleck, C. D., & Ilstrup, D. M. (1996) · Gut · doi:10.1136/gut.38.2.234 · Cited by 559 · see citing works

Long-Term Functional Outcome and Quality of Life After Stapled Restorative Proctocolectomy

Fazio, V. W., O’Riordain, M. G., Lavery, I. C., Church, J. M., Lau, P., Strong, S. A., & Hull, T. L. (1999) · Annals of Surgery · doi:10.1097/00000658-199910000-00013 · Cited by 445 · see citing works

Evaluation of Media for Selective Enumeration of Streptococcus thermophilus, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus acidophilus, and Bifidobacteria

Dave, R. I., & Shah, N. P. (1996) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(96)76513-x · Cited by 444 · see citing works

Pouchitis following heal pouch-anal anastomosis: Definition, pathogenesis, and treatment

Sandborn, W. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90832-x · Cited by 427 · see citing works

Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice

Schultz, M., Veltkamp, C., Dieleman, L. A., Grenther, W. B., Wyrick, P. B., Tonkonogy, S. L., & Sartor, R. B. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200203000-00001 · Cited by 375 · see citing works

Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens.

Shepherd, N. A., Jass, J. R., Duval, I., et al. (1987) · Journal of Clinical Pathology · doi:10.1136/jcp.40.6.601 · Cited by 358 · see citing works

A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis

Shen, B., Achkar, J., Lashner, B. A., Ormsby, A., Remzi, F. H., Brzezinski, A., Bevins, C. L., Bambrick, M. L., Seidner, D. L., & Fazio, V. W. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200111000-00004 · Cited by 349 · see citing works

Mucins and inflammatory bowel disease

Shirazi, T. (2000) · Postgraduate Medical Journal · doi:10.1136/pmj.76.898.473 · Cited by 311 · see citing works

Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis

Madden, M., McIntyre, A. S., & Nicholls, R. J. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02093783 · Cited by 301 · see citing works

Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice

O’Mahony, L., Feeney, M., O'Halloran, S., Murphy, L., Kiely, B., Fitzgibbon, J., Lee, G., O’Sullivan, G. C., Shanahan, F., & Collins, J. K. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01027.x · Cited by 298 · see citing works

The effects of Lactobacillus strains and oat fiber on methotrexate- induced enterocolitis in rats

Mao, Y., Nobaek, S., Kasravi, F. B., Adawi, D., Stenram, U., Molin, G., & Jeppsson, B. W. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8690198 · Cited by 296 · see citing works

Restorative proctocolectomy with ileal reservoir

Dozois, R. R., Goldberg, S. M., Rothenberger, D. A., et al. (1986) · International Journal of Colorectal Disease · doi:10.1007/bf01648830 · Cited by 267 · see citing works

Pouchitis following pelvic pouch operation for ulcerative colitis

Ståhlberg, D., Gullberg, K., Liljeqvist, L., Hellers, G., & Löfberg, R. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02054692 · Cited by 264 · see citing works

Pouchitis: result of microbial imbalance?

Embden, J. G. R.-V., Schouten, W. R., & van Lieshout, L. M. (1994) · Gut · doi:10.1136/gut.35.5.658 · Cited by 255 · see citing works

Development of oligonucleotide primers from the 16S-23S rRNA intergenic sequences for identifying different dairy and probiotic lactic acid bacteria by PCR

Tilsala-Timisjärvi, A., & Alatossava, T. (1997) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(97)88066-x · Cited by 250 · see citing works

Antibiotic combination therapy in patients with chronic, treatment‐resistant pouchitis

Gionchetti, P., Rizzello, F., Venturi, A., Ugolini, F., Rossi, M., Brigidi, P., Johansson, R., Ferrieri, A., Poggioli, G., & Campieri, M. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00553.x · Cited by 240 · see citing works

LAMVAB—A new selective medium for the isolation of lactobacilli from faeces

Hartemink, R., Domenech, V. R., & ROMBOUTS, F. M. (1997) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(97)00025-0 · Cited by 236 · see citing works

Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative?

Campieri, M., & Gionchetti, P. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70029-6 · Cited by 222 · see citing works

Risk Factors and True Incidence of Pouchitis in Patients after Ileal Pouch–Anal Anastomoses

Simchuk, E. J., & Thirlby, R. C. (2000) · World Journal of Surgery · doi:10.1007/s002680010136 · Cited by 219 · see citing works

Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment

Ulisse, S., Gionchetti, P., D’Alò, S., Russo, F. P., Pesce, I., Ricci, G., Rizzello, F., Helwig, U., Cifone, M. G., Campieri, M., et al. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04139.x · Cited by 214 · see citing works

Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: A randomized controlled study VS mesalamine

Campieri, M., Rizzello, F., Venturi, A., Poggioli, G., & Ugolini, F. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)85267-1 · Cited by 210 · see citing works

Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces

Kok, R. G., de Waal, A., Schut, F., Welling, G. W., Weenk, G. H., & Hellingwerf, K. J. (1996) · Applied and Environmental Microbiology · doi:10.1128/aem.62.10.3668-3672.1996 · Cited by 197 · see citing works

The Effect of Exogenous Administration ofLactobacillus reuteriR2LC and Oat Fiber on Acetic Acid-Induced Colitis in the Rat

Fabia, R. B., Ar'Rajab, A., Johansson, M. L., Wïllén, R., Andersson, R. E., Molin, G., & Bengmark, S. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309096063 · Cited by 194 · see citing works

Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea

Brigidi, P., Vitali, B., Swennen, E., Bazzocchi, G., & Matteuzzi, D. (2001) · Research in Microbiology · doi:10.1016/s0923-2508(01)01254-2 · Cited by 188 · see citing works

Raffinose-Bifidobacterium (RB) agar, a new selective medium for bifidobacteria

Hartemink, R., Kok, B. J., Weenk, G. H., et al. (1996) · Journal of Microbiological Methods · doi:10.1016/0167-7012(96)00926-8 · Cited by 148 · see citing works

Incidence and Characteristics of Pouchitis in the Kock Continent Ileostomy and the Pelvic Pouch

Svaninger, G., Nordgren, S., Öresland, T., & Hultén, L. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098275 · Cited by 128 · see citing works

Probiotics for ulcerative colitis therapy Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomized trial. Lancet 1999;354:635–9.

Mack, D. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00799-6 · Cited by 90 · see citing works

Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine

Kruis, W., Fric, P., & Stolte, M. (2001) · Gastroenterology · doi:10.1016/s0016-5085(08)80625-7 · Cited by 76 · see citing works

Probiotics in inflamatory bowel disease

Shanahan, F. (2001) · Gut · doi:10.1136/gut.48.5.609 · Cited by 60 · see citing works

Specific Detection of Bifidobacterium Strains in a Pharmaceutical Probiotic Product and in Human Feces by Polymerase Chain Reaction

Brigidi, P., Vitali, B., Swennen, E., Altomare, L., Rossi, M., & Matteuzzi, D. (2000) · Systematic and Applied Microbiology · doi:10.1016/s0723-2020(00)80070-3 · Cited by 52 · see citing works

[Pouchitis after ileal pouch-anal anastomosis].

Abitbol, V., & Chaussade, S. (1997) · PubMed · Cited by 19 · see citing works

A basic program for constructing a dispensing list for a randomised clinical trial

Tiplady, B. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01179.x · Cited by 6 · see citing works

Unravelling the pathogenesis of inflammatory bowel disease

Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364 · see citing works

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346 · see citing works

The gut microbiota and host health: a new clinical frontier

Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302 · see citing works

Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders

Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910 · see citing works

Intestinal permeability – a new target for disease prevention and therapy

Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · see citing works

Maintaining remission of ulcerative colitis with the probiotic <i>Escherichia coli</i> Nissle 1917 is as effective as with standard mesalazine

Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · see citing works

Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome

Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C. (2019) · Pathogens · doi:10.3390/pathogens8030126 · Cited by 771 · see citing works

Synbiotic therapy ( <i>Bifidobacterium longum</i> /Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766 · see citing works

Dysbiosis in inflammatory bowel disease

Tamboli, C. P., Neut, C., Desreumaux, P., & Colombel, J. F. (2004) · Gut · doi:10.1136/gut.53.1.1 · Cited by 743 · see citing works

Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits

PICARD, C., FIORAMONTI, J., FRANCOIS, A., ROBINSON, T., NEANT, F., & MATUCHANSKY, C. (2005) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/j.1365-2036.2005.02615.x · Cited by 618 · see citing works

Mechanisms of action of probiotics: Recent advances

Ng, S. C., Hart, A. L., Kamm, M. A., Stagg, A. J., & Knight, S. C. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20602 · Cited by 596 · see citing works

Modulation of human dendritic cell phenotype and function by probiotic bacteria

Hart, A. L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., Campieri, M., Kamm, M. A., Knight, S. C., & Stagg, A. J. (2004) · Gut · doi:10.1136/gut.2003.037325 · Cited by 555 · see citing works

Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis

Miele, E., Pascarella, F., Giannetti, E., Quaglietta, L., Baldassano, R. N., & Staiano, A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.118 · Cited by 517 · see citing works

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis

Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., & Tandon, R. K. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.016 · Cited by 513 · see citing works

Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases

Peterson, D. A., Frank, D. N., Pace, N. R., & Gordon, J. I. (2008) · Cell Host &amp; Microbe · doi:10.1016/j.chom.2008.05.001 · Cited by 503 · see citing works

Bifidobacteria and Their Health-Promoting Effects

Hidalgo-Cantabrana, C., Delgado, S., Ruiz, L., Ruas-Madiedo, P., Sánchez, B., & Margolles, A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0010-2016 · Cited by 490 · see citing works

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.218 · Cited by 489 · see citing works

CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis

Katoh, H., Wang, D., Daikoku, T., Sun, H., Dey, S. K., & DuBois, R. N. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.009 · Cited by 477 · see citing works

Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis

Colman, R. J., & Rubin, D. T. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.08.006 · Cited by 475 · see citing works

Using probiotics and prebiotics to improve gut health

Tuohy, K. M., Probert, H. M., Smejkal, C. W., & Gibson, G. R. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02746-6 · Cited by 420 · see citing works

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

Kim, H. J., Vazquez Roque, M. I., Camilleri, M., Stephens, D., Burton, D. D., Baxter, K., Thomforde, G., & Zinsmeister, A. R. (2005) · Neurogastroenterology &amp; Motility · doi:10.1111/j.1365-2982.2005.00695.x · Cited by 400 · see citing works

Randomized placebo‐controlled trial assessing the effect of bifidobacteria‐fermented milk on active ulcerative colitis

Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y., Sugitani, M., Imaoka, A., Otsuka, M., Hasunuma, O., Kurihara, R., Iwasaki, A., et al. (2004) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/j.1365-2036.2004.02268.x · Cited by 397 · see citing works

Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Hold, G. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1192 · Cited by 365 · see citing works

Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and Pouchitis: Meta-analysis of Randomized Controlled Trials

Shen, J., Zuo, Z.-X., & Mao, A.-P. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437495.30052.be · Cited by 364 · see citing works

The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review

Brenner, D. M., Moeller, M. J., Chey, W. D., & Schoenfeld, P. S. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.25 · Cited by 362 · see citing works

Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases

Vanderpool, C., Yan, F., & Polk, B. D. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20525 · Cited by 340 · see citing works

Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases

Packey, C. D., & Sartor, R. B. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832a8a5d · Cited by 319 · see citing works

Probiotics and Prebiotics: Effects on Diarrhea1

de Vrese, M., & Marteau, P. R. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.803s · Cited by 312 · see citing works

Probiotics in the Management of Inflammatory Bowel Disease: A Systematic Review of Intervention Studies in Adult Patients

Jonkers, D., Penders, J., Masclee, A., & Pierik, M. (2012) · Drugs · doi:10.2165/11632710-000000000-00000 · Cited by 240 · see citing works

Inhibitory effects of <i>Lactobacillus reuteri</i> on visceral pain induced by colorectal distension in Sprague-Dawley rats

Kamiya, T., Wang, L., Forsythe, P., Goettsche, G., Mao, Y., Wang, Y., Tougas, G., & Bienenstock, J. (2006) · Gut · doi:10.1136/gut.2005.070987 · Cited by 242 · see citing works

Prebiotics and probiotics; modifying and mining the microbiota

Quigley, E. M. M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.004 · Cited by 238 · see citing works

A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients

Gianotti, L. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i2.167 · Cited by 209 · see citing works

Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation

Riedel, C. U. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i23.3729 · Cited by 210 · see citing works

World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics

Guarner, F., Sanders, M. E., Szajewska, H., Cohen, H., Eliakim, R., Herrera-deGuise, C., Karakan, T., Merenstein, D., Piscoya, A., Ramakrishna, B., et al. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002002 · Cited by 209 · see citing works

The intestinal microbiota in inflammatory bowel disease

Becker, C., Neurath, M. F., & Wirtz, S. (2015) · ILAR Journal · doi:10.1093/ilar/ilv030 · Cited by 185 · see citing works

Immunomodulation by commensal and probiotic bacteria

Forsythe, P., & Bienenstock, J. (2010) · Immunological Investigations · doi:10.3109/08820131003667978 · Cited by 189 · see citing works

Lactobacillus Bacteremia Associated With Probiotic Use in a Pediatric Patient With Ulcerative Colitis

Vahabnezhad, E., Mochon, A. B., Wozniak, L. J., & Ziring, D. A. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318279abf0 · Cited by 156 · see citing works

Investigation of probiotics in multiple sclerosis

Tankou, S. K., Regev, K., Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., Vanande, I. P., Cook, S., Gandhi, R., Glanz, B., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517737390 · Cited by 156 · see citing works

Probiotic mixture VSL# 3: An overview of basic and clinical studies in chronic diseases

Cheng, F.-S., Pan, D., Chang, B., Jiang, M., & Sang, L.-X. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i8.1361 · Cited by 147 · see citing works

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer

Arthur, J. C., Gharaibeh, R. Z., Uronis, J. M., Perez-Chanona, E., Sha, W., Tomkovich, S., Mühlbauer, M., Fodor, A. A., & Jobin, C. (2013) · Scientific Reports · doi:10.1038/srep02868 · Cited by 118 · see citing works

Recommendations for Probiotic Use—2015 Update: Proceedings and Consensus Opinion

Floch, M. H., Walker, W. A., Sanders, M. E., Nieuwdorp, M., Kim, A. S., Brenner, D. A., Qamar, A. A., Miloh, T. A., Guarino, A., Guslandi, M., et al. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000420 · Cited by 119 · see citing works

The Bacteriology of Pouchitis: A Molecular Phylogenetic Analysis Using 16S rRNA Gene Cloning and Sequencing

McLaughlin, S. D., Walker, A. W., Churcher, C., Clark, S. K., Tekkis, P. P., Johnson, M. W., Parkhill, J., Ciclitira, P. J., Dougan, G., Nicholls, R. J., et al. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181e3dc8b · Cited by 114 · see citing works

Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study

Vleggaar, F. P., Monkelbaan, J. F., & van Erpecum, K. J. (2008) · European Journal of Gastroenterology &amp; Hepatology · doi:10.1097/meg.0b013e3282f5197e · Cited by 110 · see citing works

Probiotics VSL#3 Protect against Development of Visceral Pain in Murine Model of Irritable Bowel Syndrome

Distrutti, E., Cipriani, S., Mencarelli, A., Renga, B., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063893 · Cited by 107 · see citing works

Probiotics and Irritable Bowel Syndrome: Rationale, Putative Mechanisms, and Evidence of Clinical Efficacy

Camilleri, M. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00020 · Cited by 106 · see citing works

Using Probiotics in Gastrointestinal Disorders

Ringel, Y., Quigley, E. M., & Lin, H. C. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.7 · Cited by 77 · see citing works

Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta-analysis of randomized controlled trials.

Estevinho, M. M., Yuan, Y., Rodríguez‐Lago, I., Sousa‐Pimenta, M., Dias, C. C., Barreiro‐de Acosta, M., Jairath, V., & Magro, F. (2024) · United European gastroenterology journal · doi:10.1002/ueg2.12636 · Cited by 74 · see citing works

Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies

Quigley, E. M. M. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.009 · Cited by 67 · see citing works

Probiotics Used in Human Studies

Montrose, D. C., & Floch, M. H. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000165649.32371.71 · Cited by 60 · see citing works

Effects of Exopolysaccharide-Producing Probiotic Strains on Experimental Colitis in Rats

Şengül, N., Aslím, B., Uçar, G., Yücel, N., Işk, S., Bozkurt, H., Sakaoğullarí, Z., & Atalay, F. (2006) · Diseases of the Colon &amp; Rectum · doi:10.1007/s10350-005-0267-6 · Cited by 50 · see citing works

Spotlight on VSL#3 Probiotic Mixture in Chronic Inflammatory Bowel Diseases1

Chapman, T. M., Plosker, G. L., & Figgitt, D. P. (2007) · BioDrugs · doi:10.2165/00063030-200721010-00007 · Cited by 48 · see citing works

Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management

Kerman, D. H., & Deshpande, A. R. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.07.2779 · Cited by 47 · see citing works

Behavioral and Complementary Approaches for the Treatment of Irritable Bowel Syndrome

Wald, A., & Rakel, D. (2008) · Nutrition in Clinical Practice · doi:10.1177/0884533608318677 · Cited by 46 · see citing works

Probiotics in the management of gastrointestinal disease: analysis of the attitudes and prescribing practices of gastroenterologists and surgeons

CORDINA, C., SHAIKH, I., SHRESTHA, S., & CAMILLERI‐BRENNAN, J. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00534.x · Cited by 29 · see citing works

The Use of Probiotics in Functional Bowel Disease

Quigley, E. M. M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.05.008 · Cited by 20 · see citing works

Probiotics in irritable bowel syndrome: an immunomodulatory strategy?

Quigley, E. M. M. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719648 · Cited by 19 · see citing works

Vedolizumab for the treatment of ulcerative colitis

Shahidi, N. C., Bressler, B. L., & Panaccione, R. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1121231 · Cited by 2 · see citing works

Research in Brief

Baker, H. (2023) · ˜The œLancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00119-x

Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohnʼs Disease

Goren, I., Yahav, L., Tulchinsky, H., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000487 · Cited by 11 · see citing works

Pouchitis-Associated Iritis (Uveitis) Following Total Proctocolectomy and Ileal Pouch-to-Anal Anastomosis in Ulcerative Colitis

Freeman, H. J. (2001) · Canadian Journal of Gastroenterology · doi:10.1155/2001/691746 · Cited by 11 · see citing works

The Microbiome Profile In Ulcerative Colitis And PouchitisPreprint

Gao, X., Huang, D., Yang, L., He, A., Li, K., Liu, T., & Liu, G. (2021) · Research Square · doi:10.21203/rs.3.rs-714569/v1